A multi-center, double-blind, placebo-controlled therapeutic trial to determine whether natural huperzine A improves cognitive function.
Phase of Trial: Phase II
Latest Information Update: 19 Apr 2011
At a glance
- Drugs Huperzine A (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 19 Apr 2011 Primary endpoint 'Alzheimer's Disease Assessment Scale-cognitive subscale' has not been met, as published in Neurology.
- 19 Apr 2011 Results published in Neurology.
- 02 Feb 2008 Top-line results from the double-blind part of the study reported in a Neuro-Hitech media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History